Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2010; 16(46): 5845-5851
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5845
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5845
Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease
Hanne Rintamäki, Kaija-Leena Kolho, Division of Gastroenterology, Hospital for Children and Adolescents and Helsinki University Central Hospital, University of Helsinki, Helsinki, FIN-00029, Finland
Taina Sipponen, Department of Medicine, Division of Gastroenterology, Helsinki University Central Hospital, University of Helsinki, Helsinki, FIN-00029, Finland
Harri M Salo, Outi Vaarala, Immune Response Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, FIN-00300, Finland
Author contributions: Rintamäki H, Kolho KL and Vaarala O designed the research; Rintamäki H and Salo HM performed the research; Rintamäki H, Sipponen T, Salo HM, Vaarala O and Kolho KL analyzed the data; Rintamäki H, Sipponen T, Salo HM, Vaarala O and Kolho KL wrote the paper.
Supported by The Finnish Cultural Foundation, the Finnish Pediatric Research Foundation, the Päivikki and Sakari Sohlberg Foundation, the Helsinki University Central Hospital Grant, the Orion-Farmos Research Foundation, and the Mary and George C Ehrnrooth Foundation
Correspondence to: Dr. Hanne Rintamäki, Division of Gastroenterology, Hospital for Children and Adolescents and Helsinki University Central Hospital, University of Helsinki, Helsinki, FIN-00029, Finland. hanne.rintamaki@helsinki.fi
Telephone: +358-40-8388083 Fax: +358-9-47172599
Received: May 25, 2010
Revised: July 27, 2010
Accepted: August 3, 2010
Published online: December 14, 2010
Revised: July 27, 2010
Accepted: August 3, 2010
Published online: December 14, 2010
Core Tip